Indianapolis, IN10 days ago
We are also Indiana’s exclusive provider of pediatric stem cell transplants and CAR T-cell therapy as well as emphasis on Clinical Research with Membership in Children’s Oncology Group Phase 1/PEP-CTN, National Experimental Therapeutics (NExT) Consortium, Neurofibromatosis Clinical Trial Consortium (NFCTC), Pacific Pediatric, Neuro-Oncology Consortium (PNOC). Each year, we care for over 300 new oncology patients and perform over 13,000 outpatient visits, offering expert care for leukemia, solid tumors, brain tumors, hematopoietic and stem cell transplants, as well as general hematology, sickle cell disease, thalassemia, bone marrow failure syndromes, hemophilia, and other coagulation disorders.